Safety and Effectiveness of Brigatinib in Anaplastic Lymphoma Kinase (ALK) Positive Metastatic Non-Small Cell Lung Cancer (NSCLC) in Argentina: A Post-Marketing Surveillance Study
布加替尼治疗阿根廷间变性淋巴瘤激酶（ALK）阳性转移性非小细胞肺癌（NSCLC）的安全性和有效性：一项上市后监测研究
期刊:Drugs-Real World Outcomes
影响因子:1.9
doi:10.1007/s40801-025-00484-z
Martin, Claudio; Malcervelli, Gabriela Ileana; Martinengo, Gastón Lucas; Levit, Patricio; Servienti, Patricio; Malaver, Elisa; Brion, Laura; Patronella, Vanesa; Zumárraga, Andrea; Zarba, Jose
肺癌
肿瘤
肿瘤免疫
信号转导
ALK
淋巴瘤
CLC
细胞生物学
